Our research into rare cancers
120 years of life-saving discoveries
Our scientists have been at the forefront of cancer research since 1902.
Thanks to you, we’ve come so far. And we will go much further.
Together, we will beat cancer.
Our research is saving lives
Together, rare cancers make up more than 20% of all cancer cases. We’ve contributed to several advances for people with rare cancers. We ran some of the first trials for people with uveal melanoma and neuroendocrine tumours, and showed that the drug Glivec was effective for some advanced gastro-intestinal stromal tumours (GIST). And we set up and continue to support the International Rare Cancers Initiative, which is developing clinical trials worldwide to find new treatments for rare cancers.